Mental Health Awareness Website 'Kokoro no Hidamari' Renewed with Expanded New Content on Generalized Anxiety Disorder (GAD)
NQ Score
80/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Viatris Pharmaceuticals has renewed its mental health website, 'Kokoro no Hidamari,' expanding content on Generalized Anxiety Disorder (GAD) following the approval of Japan's first GAD treatment drug.
AI Analysis
Frequently Asked Questions
- Q: What is Generalized Anxiety Disorder (GAD)?
- A: It is a condition characterized by chronic excessive worry and anxiety about multiple events, causing symptoms such as insomnia and muscle tension that interfere with daily life.
- Q: Are there any treatments for GAD in Japan?
- A: Yes. On March 23, 'Efexor SR Capsules' became the first approved treatment for GAD in Japan.
- Q: Is there a way to check if I have GAD?
- A: You can use a free self-check tool, reviewed by specialists, on the 'Kokoro no Hidamari' website operated by Viatris Pharmaceutical.